Detection of metallo-beta-lactamase producing Pseudomonas aeruginosa in intensive care units

Australasian Medical Journal

Volumn 6, Issue 12, 2013, Pages 686-693

  Kali, Arunava ^a   Srirangaraj, Sreenivasan ^a   Kumar, Shailesh ^a   Divya, Hema A ^a   Kalyani, Akhila ^a   Umadevi, Sivaraman ^a  

^a MAHATMA GANDHI MEDICAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Infection control; Metallo beta lactamases; Multidrug resistance; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; EDETIC ACID; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN; POLYMYXIN B; TAZOBACTAM; TICARCILLIN;

ADULT; AGED; ALCOHOLISM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; CHILD; CLINICAL ARTICLE; COMBINED DISK METHOD; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE DISK SYNERGY TEST; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IN VITRO STUDY; INFANT; INTENSIVE CARE UNIT; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIDRUG RESISTANCE; NEWBORN; NONHUMAN; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SCREENING TEST;

EID: 84891501633     PISSN: 18361935     EISSN: None     Source Type: Journal    
DOI: 10.4066/AMJ.2013.1824     Document Type: Article

References (26)

1. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis. 2006;43 Suppl 2:S43-8.
2. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallobeta-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005;18:306-25.
3. Hammami S, Boutiba-Ben Boubaker I, Ghozzi R, Saidani M, Amine S, Ben Redjeb S. Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in a kidney transplantation unit. Diagn Pathol. 2011;6:106.
4. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol. 2006;44:3139-44.
5. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39:1211-33.
6. De AS, Kumar SH, Baveja SM. Prevalence of metallo-betalactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital. Indian J Crit Care Med. 2010;14:217-9.
7. Peleg AY, Franklin C, Bell JM, Spelman DW. Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gramnegative pathogens in a clinical setting in Australia. Clin Infect Dis. 2005;41:1549-56.
8. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-17.
9. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. Microb Drug Resist. 2005;11:68-74.
10. Zavascki AP, Barth AL, Goncalves AL, Moro AL, Fernandes JF, Martins AF, Ramos F, Goldani LZ. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother. 2006;58:387-92.
11. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. CLSI document M100-S20. Wayne, PA: CLSI; 2010.
12. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallobeta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40:3798-801.
13. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003;41:4623-9.
14. Zavascki AP, Barth AL, Gaspareto PB, Goncalves AL, Moro AL, Fernandes JF, Goldani LZ. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals. J Antimicrob Chemother. 2006;58:882-5.
15. Marra AR, Pereira CA, Gales AC, Menezes LC, Cal RG, de Souza JM, Edmond MB, Faro C, Wey SB. Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother. 2006;50:388-90.
16. Tsakris A, Poulou A, Kristo I, Pittaras T, Spanakis N, Pournaras S, Markou F. Large dissemination of VIM-2-metallo-beta-lactamase-producing Pseudomonas aeruginosa strains causing health care-associated community-onset infections. J Clin Microbiol. 2009;47:3524-9.
17. Storm DR, Rosenthal KS, Swanson PE. Polymyxin and related peptide antibiotics. Annu Rev Biochem. 1977;46:723-63.
18. Falagas M, Kasiakou S. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care. 2006;10:R27.
19. Nouer SA, Nucci M, de-Oliveira MP, Pellegrino FL, Moreira BM. Risk factors for acquisition of multidrugresistant Pseudomonas aeruginosa producing SPM metallobeta-lactamase. Antimicrob Agents Chemother. 2005;49:3663-7.
20. John S, Balagurunathan R. Metallo beta lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii. Indian J Med Microbiol. 2011;29:302-4.
21. Sharma M, Yadav S, Chaudhary U. Metallo-betalactamase Producing Pseudomonas aeruginosa in Neonatal Septicemia. J Lab Physicians. 2010;2:14-6.
22. Tan J, Pitout JD, Guttman DS. New and sensitive assay for determining Pseudomonas aeruginosa metallo-betalactamase resistance to imipenem. J Clin Microbiol. 2008;46:1870-2.
23. Samuelsen O, Buaro L, Giske CG, Simonsen GS, Aasnaes B, Sundsfjord A. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country. J Antimicrob Chemother. 2008;61:827-30.
24. Behera B, Mathur P, Das A, Kapil A, Sharma V. An evaluation of four different phenotypic techniques for detection of metallo-beta-lactamase producing Pseudomonas aeruginosa. Indian J Med Microbiol. 2008;26:233-7.
25. Berges L, Rodriguez-Villalobos H, Deplano A, Struelens MJ. Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-beta-lactamaseproducing Pseudomonas aeruginosa. J Antimicrob Chemother. 2007;59:812-3.
26. Shanthi M, Sekar U. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes. J Assoc Physicians India. 2009;57:636, 8-40, 45.